Pathway-based expression profile for breast cancer diagnoses

Microarray experiments have made possible to identify breast cancer marker gene signatures. However, gene expression-based signatures present limitations because they do not consider metabolic role of the genes and are affected by genetic heterogeneity across patient cohorts. Considering the activity of entire pathways rather than the expression levels of individual genes can be a way to exceed these limits. We evaluated and compared five methods of pathway-level aggregation of gene expression data. Our results confirmed the important role of pathway expression profile in breast cancer diagnostic classification (accuracy >90%). However, although assessed on a limited number of samples and datasets, this study shows that using dissimilarity representation among patients does not improve the classification of pathway-based expression profiles.

[1]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[2]  Giancarlo Mauri,et al.  Copy-Number Alterations for Tumor Progression Inference , 2013, AIME.

[3]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[4]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[5]  G. M. Di Guglielmo,et al.  GPR54 (KISS1R) Transactivates EGFR to Promote Breast Cancer Cell Invasiveness , 2011, PloS one.

[6]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[7]  Joshy George,et al.  Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. , 2006, Cancer research.

[8]  D. Rose,et al.  Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. , 2007, Endocrine-related cancer.

[9]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[10]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Mauri,et al.  Combination of gene expression and genome copy number alteration has a prognostic value for breast cancer , 2013, 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[12]  Seungwoo Hwang.  Comparison and evaluation of pathway-level aggregation methods of gene expression data , 2012, BMC Genomics.

[13]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[14]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Sayan Mukherjee,et al.  Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles , 2006, ISMB.

[16]  Buddhini Samarasinghe,et al.  The Hallmarks of Cancer: Fighting Back , 2013 .

[17]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[18]  D. Conklin,et al.  PPARγ maintains ERBB2-positive breast cancer stem cells , 2013, Oncogene.

[19]  Francisco Azuaje,et al.  Systems-based biological concordance and predictive reproducibility of gene set discovery methods in cardiovascular disease , 2011, J. Biomed. Informatics.

[20]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[21]  Qing Wang,et al.  Towards precise classification of cancers based on robust gene functional expression profiles , 2005, BMC Bioinformatics.

[22]  Doheon Lee,et al.  Inferring Pathway Activity toward Precise Disease Classification , 2008, PLoS Comput. Biol..

[23]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[24]  M. J. van de Vijver,et al.  Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.

[25]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[26]  Giancarlo Mauri,et al.  Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference , 2014, Journal of Clinical Bioinformatics.

[27]  Ingo Mierswa,et al.  YALE: rapid prototyping for complex data mining tasks , 2006, KDD '06.

[28]  Marilie D Gammon,et al.  Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study. , 2008, Carcinogenesis.

[29]  Robert V Farese,et al.  Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.